Cytogenetic complexity and heterogeneity in intravascular lymphoma

Aims To characterise the karyotypic abnormalities and heterogeneities in intravascular lymphoma (IVL). Methods G-banded karyotyping was performed on biopsy specimens from a single-centre IVL cohort comprising intravascular large B-cell lymphoma (IVLBCL, n=12) and NK/T-cell lymphoma (IVNKTCL, n=1). Results Five IVLBCL cases and one IVNKTCL case (total 46%) were found to have normal karyotypes, and the cytogenetic abnormalities observed in the other seven IVLBCL cases (54%) were investigated further. These seven karyotypes were uniformly complex with an average of 13 aberrations. The seven cases all had abnormalities involving chromosome 6, with 57% involving structural abnormalities at 6q13, and chromosome 8, with 43% involving abnormalities at 8p11.2. In addition, 71% had aberrations at 19q13. On average, 4.4 chromosomal gains and losses were detected per case. Cytogenetic heterogeneities were observed in six cases (86%) and tetraploidy in three cases (43%). There was no significant difference in progression-free survival (p=0.92) and overall survival (p=0.61) between the IVLBCL cases with complex and normal karyotypes. Conclusion Approximately half of IVLBCL cases had a highly heterogeneous pattern of karyotypes with different clonal numerical and structural chromosome aberrations.

[1]  L. Medeiros,et al.  Chronic myeloid leukemia with insertion-derived BCR–ABL1 fusion: redefining complex chromosomal abnormalities by correlation of FISH and karyotype predicts prognosis , 2020, Modern Pathology.

[2]  W. Chuang,et al.  Intravascular Large B-cell lymphoma: A case series and review of literatures , 2020, Biomedical journal.

[3]  Kazuma Uesaka,et al.  Transcriptome complexity in intravascular NK/T-cell lymphoma , 2020, Journal of Clinical Pathology.

[4]  S. Verstovsek,et al.  Systematic use of fluorescence in‐situ hybridisation and clinicopathological features in the screening of PDGFRB rearrangements of patients with myeloid/lymphoid neoplasms , 2020, Histopathology.

[5]  Xi-chuan Yang,et al.  Cutaneous intravascular NK/T‐cell lymphoma , 2020, The Australasian journal of dermatology.

[6]  Michael L. Wang,et al.  CD5-negative Mantle Cell Lymphoma , 2019, The American journal of surgical pathology.

[7]  Jeffery A. Jones,et al.  Clinicopathological and molecular characteristics of extramedullary acute myeloid leukaemia , 2019, Histopathology.

[8]  Hiroki Kobayashi,et al.  Diagnosis of intravascular large B cell lymphoma: novel insights into clinicopathological features from 42 patients at a single institution over 20 years , 2019, British journal of haematology.

[9]  Ping Wang,et al.  Intravascular large NK/T-cell lymphoma: a variant of extranodal NK/T-cell lymphoma, nasal type? , 2019, European Journal of Dermatology.

[10]  K. Ohshima,et al.  Methotrexate-associated Lymphoproliferative Disorders in Patients With Rheumatoid Arthritis , 2019, The American journal of surgical pathology.

[11]  A. Mansoor,et al.  Diffuse large B-cell lymphoma in Southeast Asian cohort: expression patterns of B-cell receptor (BCR) repertoire and its linkage with molecular subtypes and response to R-CHOP therapy , 2019, Journal of Clinical Pathology.

[12]  Sagi Abelson,et al.  Emerging patterns in clonal haematopoiesis , 2019, Journal of Clinical Pathology.

[13]  F. Hodi,et al.  Detection of clinically relevant immune checkpoint markers by multicolor flow cytometry , 2019, Journal of biological methods.

[14]  T. Itoh,et al.  Intravascular NK/T-cell lymphoma: clinicopathological and integrated molecular analysis of two cases provides a clue to disease pathogenesis , 2019, Journal of Clinical Pathology.

[15]  A. Bagg,et al.  Clinical, immunophenotypic, and genomic findings of acute undifferentiated leukemia and comparison to acute myeloid leukemia with minimal differentiation: a study from the bone marrow pathology group , 2019, Modern Pathology.

[16]  Xiaoyan Zhou,et al.  Integrative analysis of PD‐L1 DNA status, mRNA status and protein status, and their clinicopathological correlation, in diffuse large B‐cell lymphoma , 2019, Histopathology.

[17]  I. Gut,et al.  Clonal dynamics monitoring during clinical evolution in chronic lymphocytic leukaemia , 2019, Scientific Reports.

[18]  M. Delledonne,et al.  Insertional translocation involving an additional nonchromothriptic chromosome in constitutional chromothripsis: Rule or exception? , 2018, Molecular genetics & genomic medicine.

[19]  T. Hishima,et al.  Age and CD20 Expression Are Significant Prognostic Factors in Human Herpes Virus-8-negative Effusion-based Lymphoma , 2018, The American journal of surgical pathology.

[20]  S. Ascani,et al.  Intravascular NK/T-cell lymphoma, Epstein–Barr virus positive with multiorgan involvement: a clinical dilemma , 2018, BMC Cancer.

[21]  K. Naresh,et al.  A rare case of renal intravascular NK/T-cell lymphoma. , 2018, Blood.

[22]  J. Ishikawa,et al.  Pure intravascular recurrence of CD5-positive diffuse large B-cell lymphoma primarily arising from the nasal cavities , 2018, Diagnostic Pathology.

[23]  C. Grant,et al.  FISH studies in DLBCL: correlations with cell of origin: the Irish experience , 2018, Journal of Clinical Pathology.

[24]  Jinjun Cheng,et al.  Recurrent Cytogenetic Abnormalities in Intravascular Large B-Cell Lymphoma , 2018, American journal of clinical pathology.

[25]  H. Prince,et al.  Novel genomic findings in multiple myeloma identified through routine diagnostic sequencing , 2018, Journal of Clinical Pathology.

[26]  M. Seto,et al.  Clinicopathological analysis of polyploid diffuse large B-cell lymphoma , 2018, PloS one.

[27]  G. Gu,et al.  A rapid and reliable chromosome analysis method for products of conception using interphase nuclei , 2018, Molecular genetics & genomic medicine.

[28]  A. Chiu,et al.  De novo pure erythroid leukemia: refining the clinicopathologic and cytogenetic characteristics of a rare entity , 2018, Modern Pathology.

[29]  S. Swerdlow,et al.  Comparison of Myocyte Enhancer Factor 2B Versus Other Germinal Center-associated Antigens in the Differential Diagnosis of B-Cell Non-Hodgkin Lymphomas , 2018, The American journal of surgical pathology.

[30]  S. Rodríguez-Pinilla,et al.  Cutaneous intravascular natural killer/T cell lymphoma with peculiar immunophenotype , 2017, Histopathology.

[31]  S. Swerdlow WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues , 2017 .

[32]  E. Jaffe,et al.  Intravascular large cell lymphoma of NK/T-cell type, EBV positive. , 2017, Blood.

[33]  N. McGranahan,et al.  Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future , 2017, Cell.

[34]  T. Petrella,et al.  Retrospective study of intravascular large B-cell lymphoma cases diagnosed in Quebec , 2017, Medicine.

[35]  Chaofu Wang,et al.  Intravascular NK/T-cell lymphoma in the testis: a novel case report and review of the literature. , 2017, International journal of clinical and experimental pathology.

[36]  Su Yao,et al.  Intravascular NK/T-cell lymphoma: a series of four cases. , 2017, International journal of clinical and experimental pathology.

[37]  Changzheng Huang,et al.  Intravascular NK/T‐cell lymphoma: a report of five cases with cutaneous manifestation from China , 2015, Journal of cutaneous pathology.

[38]  A. Alhumidi Cutaneous Intravascular NK/T-cell lymphoma mimic panniculitis clinically, case report and literature brief review , 2015, Diagnostic Pathology.

[39]  Tonghua Liu,et al.  Intravascular NK-cell lymphoma: a case report and review of the literature , 2015, Diagnostic Pathology.

[40]  M. Waki,et al.  Intravascular large B-cell lymphoma manifesting as cholecystitis: report of an Asian variant showing gain of chromosome 18 with concurrent deletion of chromosome 6q. , 2014, International journal of clinical and experimental pathology.

[41]  M. Linden,et al.  Early diagnosis of intravascular large B-cell lymphoma: clues from routine blood smear morphologic findings. , 2014, Laboratory medicine.

[42]  J. An,et al.  Cutaneous intravascular natural killer-cell lymphoma: a case report and review of the literature. , 2014, American journal of clinical pathology.

[43]  T. Park,et al.  Intravascular Cytotoxic T-Cell Lymphoma in a Young Immunocompetent Woman , 2014, Annals of dermatology.

[44]  N. Gebauer,et al.  Intravascular natural killer cell lymphoma mimicking mycosis fungoides: a case report and review of the literature. , 2014, The American Journal of dermatopathology.

[45]  L. Staudt,et al.  Diffuse large B-cell lymphoma—treatment approaches in the molecular era , 2014, Nature Reviews Clinical Oncology.

[46]  Zhongsheng Min,et al.  Cutaneous intravascular NK-cell lymphoma. , 2013, European journal of dermatology : EJD.

[47]  H. Matsuoka,et al.  Gain of 11q by an additional ring chromosome 11 and trisomy 18 in CD5-positive intravascular large B-cell lymphoma. , 2013, Journal of clinical and experimental hematopathology : JCEH.

[48]  Shibo Li,et al.  Intravascular large B-cell lymphoma with hemophagocytic syndrome (Asian variant) in a Caucasian patient. , 2012, International journal of clinical and experimental pathology.

[49]  Chieh-Shan Wu,et al.  Cutaneous intravascular natural killer-cell lymphoma: a rare case and review of the literature. , 2011, Acta dermato-venereologica.

[50]  H. Ohno,et al.  Intravascular large B-cell lymphoma associated with t(14;19)(q32;q13) translocation. , 2011, Internal medicine.

[51]  A. Arbini,et al.  Segmental tandem triplication of the MLL gene in an intravascular large B-cell lymphoma with multisystem involvement: a comprehensive morphologic, immunophenotypic, cytogenetic, and molecular cytogenetic antemortem study. , 2009, Archives of pathology & laboratory medicine.

[52]  T. Naoe,et al.  Presentation and management of intravascular large B-cell lymphoma. , 2009, The Lancet. Oncology.

[53]  Kai Fu,et al.  A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy , 2009, Clinical Cancer Research.

[54]  R. Lothe,et al.  Reverse painting of microdissected chromosome 19 markers in ovarian carcinoma identifies a complex rearrangement map , 2009, Genes, chromosomes & cancer.

[55]  E. Morii,et al.  NK‐cell intravascular lymphomatosis – a mini‐review , 2008, European journal of haematology.

[56]  C. Massone,et al.  Intravascular Large T-cell or NK-cell Lymphoma: A Rare Variant of Intravascular Large Cell Lymphoma With Frequent Cytotoxic Phenotype and Association With Epstein-Barr Virus Infection , 2008, The American journal of surgical pathology.

[57]  Robert Tibshirani,et al.  LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[58]  Sang Joon Kim,et al.  Intravascular large cell lymphoma of the natural killer cell type. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[59]  T. Yoshino,et al.  Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5. , 2007, Blood.

[60]  J. Czyż,et al.  Intravascular large B-cell lymphoma associated with a near-tetraploid karyotype, rearrangement of BCL6, and a t(11;14)(q13;q32). , 2006, Cancer genetics and cytogenetics.

[61]  T. Kuo,et al.  Cutaneous intravascular NK-cell lymphoma: report of a rare variant associated with Epstein-Barr virus. , 2006, The American journal of surgical pathology.

[62]  C J L M Meijer,et al.  Immunohistochemical profiling based on Bcl‐2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma , 2006, The Journal of pathology.

[63]  F. Jardin,et al.  Intravascular large B-Cell lymphoma with bone marrow involvement and superior sagittal sinus thrombosis: report of a case successfully treated with a CHOP/rituximab combination regimen. , 2005, Clinical lymphoma.

[64]  C. Chen,et al.  First reported cases of intravascular large cell lymphoma of the NK cell type: clinical, histologic, immunophenotypic, and molecular features. , 2005, American journal of clinical pathology.

[65]  L. Staudt,et al.  Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. , 2004, Blood.

[66]  R. Gascoyne,et al.  Multicolor Karyotyping and Clinicopathological Analysis of Three Intravascular Lymphoma Cases , 2003, Modern Pathology.

[67]  H. Müller-Hermelink,et al.  Cytotoxic/natural killer cell cutaneous lymphomas , 2003, Cancer.

[68]  Barbara J. Trask,et al.  Human genetics and disease: Human cytogenetics: 46 chromosomes, 46 years and counting , 2002, Nature Reviews Genetics.

[69]  T. Honda,et al.  Chromosomal Aberrations in Intravascular Lymphomatosis , 2002, American journal of clinical oncology.

[70]  T. Suchi,et al.  An Asian variant of intravascular large B‐cell lymphoma: clinical, pathological and cytogenetic approaches to diffuse large B‐cell lymphoma associated with haemophagocytic syndrome , 2000, British journal of haematology.

[71]  T. Ito,et al.  Chromosomal aberrations detected after stimulation with lipopolysaccharide in a patient with Asian variant intravascular lymphomatosis. , 2000, Cancer Genetics and Cytogenetics.

[72]  T. Saito,et al.  Intravascular lymphomatosis presenting as an ascending cauda equina: conus medullaris syndrome: remission after biweekly CHOP therapy , 1999, Journal of neurology, neurosurgery, and psychiatry.

[73]  S. Nakamura,et al.  An Asian variant of intravascular lymphomatosis: an updated review of malignant histiocytosis-like B-cell lymphoma. , 1999, Leukemia & lymphoma.

[74]  H. Hirai,et al.  B‐cell lymphoma associated with haemophagocytic syndrome: a clinical, immunological and cytogenetic study , 1999, British journal of haematology.

[75]  D. Davey,et al.  Angiotrophic lymphoma. Presentation in uterine vessels with cytogenetic studies. , 1990, Archives of pathology & laboratory medicine.

[76]  C. Lombard,et al.  Immunohistochemical and cytogenetic studies indicate that malignant angioendotheliomatosis is a primary intravascular (angiotropic) lymphoma , 1990, Cancer.

[77]  Iscn International System for Human Cytogenetic Nomenclature , 1978 .